Localized Orbitofrontal and Subcortical Metabolic Changes and Predictors of Response to Paroxetine Treatment in Obsessive-Compulsive Disorder

[1]  P. Blier,et al.  Effect of long-term administration of antidepressant treatments on serotonin release in brain regions involved in obsessive–compulsive disorder , 1999, Biological Psychiatry.

[2]  Michael E Phelps,et al.  FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive compulsive disorder , 1998, Psychiatry Research: Neuroimaging.

[3]  A L Brody,et al.  Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder , 1998, British Journal of Psychiatry.

[4]  D. Rosenberg,et al.  Case study: caudate glutamatergic changes with paroxetine therapy for pediatric obsessive-compulsive disorder. , 1998, Journal of the American Academy of Child and Adolescent Psychiatry.

[5]  L. Bellodi,et al.  Frontal lobe dysfunction in obsessive-compulsive disorder and major depression: a clinical-neuropsychological study , 1998, Psychiatry Research.

[6]  Nathaniel M. Alpert,et al.  The functional neuroanatomy of anxiety: a study of three disorders using positron emission tomography and symptom provocation , 1997, Biological Psychiatry.

[7]  J. Pierri,et al.  Frontostriatal measurement in treatment-naive children with obsessive-compulsive disorder. , 1997, Archives of general psychiatry.

[8]  L. Koran,et al.  Rapid benefit of intravenous pulse loading of clomipramine in obsessive-compulsive disorder. , 1997, The American journal of psychiatry.

[9]  D. Joel,et al.  The connections of the primate subthalamic nucleus: indirect pathways and the open-interconnected scheme of basal ganglia-thalamocortical circuitry , 1997, Brain Research Reviews.

[10]  M E Phelps,et al.  Automated image registration for FDOPA PET studies. , 1996, Physics in medicine and biology.

[11]  J. Zohar,et al.  Paroxetine versus Clomipramine in the Treatment of Obsessive–Compulsive Disorder , 1996, British Journal of Psychiatry.

[12]  Y. Smith,et al.  The subthalamic nucleus and the external pallidum: two tightly interconnected structures that control the output of the basal ganglia in the monkey , 1996, Neuroscience.

[13]  J. R. Baker,et al.  Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. , 1996, Archives of general psychiatry.

[14]  M E Phelps,et al.  Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. , 1996, Archives of general psychiatry.

[15]  Terry E. Goldberg,et al.  PET validation of a novel prefrontal task: Delayed response alternation. , 1996 .

[16]  D. Zald,et al.  Anatomy and function of the orbital frontal cortex, I: anatomy, neurocircuitry; and obsessive-compulsive disorder. , 1996, The Journal of neuropsychiatry and clinical neurosciences.

[17]  D. Zald,et al.  Anatomy and function of the orbital frontal cortex, II: Function and relevance to obsessive-compulsive disorder. , 1996, The Journal of neuropsychiatry and clinical neurosciences.

[18]  A. Brody,et al.  Brain Mediation of Obsessive-Compulsive Disorder Symptoms: Evidence From Functional Brain Imaging Studies in the Human and Nonhuman Primate. , 1996, Seminars in clinical neuropsychiatry.

[19]  P. Blier,et al.  Alteration of Serotonin Release in the Guinea Pig Orbito-Frontal Cortex by Selective Serotonin Reuptake Inhibitors , 1995, Neuropsychopharmacology.

[20]  M Ashtari,et al.  Reduced caudate nucleus volume in obsessive-compulsive disorder. , 1995, Archives of general psychiatry.

[21]  L. Bellodi,et al.  Frontal-Lobe Dysfunction in Schizophrenia and Obsessive-Compulsive Disorder - A Neuropsychological Study , 1995, Brain and Cognition.

[22]  A. Parent,et al.  Functional anatomy of the basal ganglia. I. The cortico-basal ganglia-thalamo-cortical loop , 1995, Brain Research Reviews.

[23]  N. Swerdlow Serotonin, obsessive compulsive disorder and the basal ganglia , 1995 .

[24]  Sung-Cheng Huang,et al.  A general technique for interstudy registration of multifunction and multimodality images , 1994 .

[25]  C D Frith,et al.  Functional Anatomy of Obsessive–Compulsive Phenomena , 1994, British Journal of Psychiatry.

[26]  S. Rauch,et al.  Managing the patient with treatment-resistant obsessive compulsive disorder: current strategies. , 1994, The Journal of clinical psychiatry.

[27]  Suck-Won Kim,et al.  The Yale-Brown Obsessive-Compulsive Scale: Measures of internal consistency , 1994, Psychiatry Research.

[28]  N. Alpert,et al.  Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. , 1994, Archives of general psychiatry.

[29]  A. McIntyre,et al.  A double-blind, placebo-controlled study of fluoxetine in patients with DSM-III-R obsessive-compulsive disorder , 1993, European Neuropsychopharmacology.

[30]  G. Tollefson,et al.  Pharmacotherapy of obsessive compulsive disorder‐experience with fluoxetine , 1993, International Clinical Psychopharmacology.

[31]  G. Small,et al.  Reliability of drawing regions of interest for positron emission tomographic data , 1992, Psychiatry Research: Neuroimaging.

[32]  T. Insel,et al.  Toward a neuroanatomy of obsessive-compulsive disorder. , 1992, Archives of general psychiatry.

[33]  J. Mazziotta,et al.  Caudate glucose metabolic rate changes with both drug and behavior therapy for obsessive-compulsive disorder. , 1992, Archives of general psychiatry.

[34]  Richard S. J. Frackowiak,et al.  Obsessional slowness. Functional studies with positron emission tomography. , 1991, Brain : a journal of neurology.

[35]  Karl J. Friston,et al.  Comparing Functional (PET) Images: The Assessment of Significant Change , 1991, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[36]  D. Murphy,et al.  Local cerebral glucose metabolic rates in obsessive-compulsive disorder. Patients treated with clomipramine. , 1990, Archives of general psychiatry.

[37]  A. Parent,et al.  Immunohistochemical study of the serotoninergic innervation of the basal ganglia in the squirrel monkey , 1990, The Journal of comparative neurology.

[38]  A. Parent,et al.  Efferent projections of the subthalamic nucleus in the squirrel monkey as studied by the PHA‐L anterograde tracing method , 1990, The Journal of comparative neurology.

[39]  W. Goodman,et al.  The Yale-Brown Obsessive Compulsive Scale. I. Development, use, and reliability. , 1989, Archives of general psychiatry.

[40]  J. Rapoport,et al.  Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. , 1989, Archives of general psychiatry.

[41]  T. Nordahl,et al.  Cerebral glucose metabolic rates in obsessive compulsive disorder. , 1989, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[42]  G C Curtis,et al.  Neurophysiologic dysfunction in basal ganglia/limbic striatal and thalamocortical circuits as a pathogenetic mechanism of obsessive-compulsive disorder. , 1989, The Journal of neuropsychiatry and clinical neurosciences.

[43]  J. Mazziotta,et al.  Cerebral glucose metabolic rates in nondepressed patients with obsessive-compulsive disorder. , 1988, The American journal of psychiatry.

[44]  Insel Tr Obsessive-compulsive disorder: a neuroethological perspective. , 1988 .

[45]  T. Insel Obsessive-compulsive disorder: a neuroethological perspective. , 1988, Psychopharmacology bulletin.

[46]  J. Mazziotta,et al.  Local cerebral glucose metabolic rates in obsessive-compulsive disorder. A comparison with rates in unipolar depression and in normal controls. , 1987, Archives of general psychiatry.

[47]  G. E. Alexander,et al.  Parallel organization of functionally segregated circuits linking basal ganglia and cortex. , 1986, Annual review of neuroscience.

[48]  T. McGlashan The Chestnut Lodge follow-up study. II. Long-term outcome of schizophrenia and the affective disorders. , 1984, Archives of general psychiatry.

[49]  J. Fleiss,et al.  The global assessment scale. A procedure for measuring overall severity of psychiatric disturbance. , 1976, Archives of general psychiatry.

[50]  Charles M. Butter,et al.  Perseveration in extinction and in discrimination reversal tasks following selective frontal ablations in Macaca mulatta , 1969 .

[51]  M. Hamilton A RATING SCALE FOR DEPRESSION , 1960, Journal of neurology, neurosurgery, and psychiatry.